(Corrects spelling of company in first paragraph)
(Reuters) – Johnson & Johnson said on Tuesday it will acquire medical technology provider Abiomed Inc for an upfront payment of $380 per share in cash, corresponding to an enterprise value of nearly $16.6 billion.
(Reporting by Raghav Mahobe in Bengaluru; Editing by Shounak Dasgupta)